| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Hanyu, H Sakurai, T Iwamoto, M Takasaki, H Shindo, K Ab. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. Journal of the neurological sciences. vol 156. issue 2. 1998-08-27. PMID:9588857. |
we investigated the changes in water diffusion in the hippocampus and the temporal white matter (the temporal stem) in eight patients with possible alzheimer's disease (ad), 10 patients with probable ad, and 10 age-matched controls, using coronal diffusion-weighted magnetic resonance (mr) imaging. |
1998-08-27 |
2023-08-12 |
Not clear |
| E M Reiman, A Uecker, R J Caselli, S Lewis, D Bandy, M J de Leon, S De Santi, A Convit, D Osborne, A Weaver, S N Thibodea. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Annals of neurology. vol 44. issue 2. 1998-08-25. PMID:9708558. |
hippocampal volumes in cognitively normal persons at genetic risk for alzheimer's disease. |
1998-08-25 |
2023-08-12 |
human |
| E M Reiman, A Uecker, R J Caselli, S Lewis, D Bandy, M J de Leon, S De Santi, A Convit, D Osborne, A Weaver, S N Thibodea. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Annals of neurology. vol 44. issue 2. 1998-08-25. PMID:9708558. |
whereas pet measurements of cerebral glucose metabolism begin to decrease before the onset of memory decline, mri measurements of hippocampal volume begin to decrease in conjunction with memory decline in cognitively normal persons at risk for alzheimer's disease. |
1998-08-25 |
2023-08-12 |
human |
| V H Oleana, A Salehi, D F Swaa. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients. Neuroreport. vol 9. issue 7. 1998-08-24. PMID:9631446. |
increased expression of the tiar protein in the hippocampus of alzheimer patients. |
1998-08-24 |
2023-08-12 |
Not clear |
| V H Oleana, A Salehi, D F Swaa. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients. Neuroreport. vol 9. issue 7. 1998-08-24. PMID:9631446. |
using a monoclonal antibody against tiar, we stained different areas of the hippocampus from seven controls and 14 patients with alzheimer's disease (ad). |
1998-08-24 |
2023-08-12 |
Not clear |
| M D Thompson, K Knee, C J Golde. Olfaction in persons with Alzheimer's disease. Neuropsychology review. vol 8. issue 1. 1998-08-11. PMID:9585920. |
the need for low cost, noninvasive procedures for aiding in the diagnosis and understanding of alzheimer's disease (ad) has led to theories and procedures examining the role of olfactory disorders because of the finding that the brains of ad patients invariably exhibit neuropathology in the hippocampus and entorhinal cortex. |
1998-08-11 |
2023-08-12 |
Not clear |
| A I Holodny, A E George, J Golomb, M J de Leon, A J Kalni. The perihippocampal fissures: normal anatomy and disease states. Radiographics : a review publication of the Radiological Society of North America, Inc. vol 18. issue 3. 1998-08-06. PMID:9599389. |
a marker for alzheimer disease and mesial temporal sclerosis is atrophy of the hippocampus and associated dilatation of the phfs. |
1998-08-06 |
2023-08-12 |
Not clear |
| J J Pei, I Grundke-Iqbal, K Iqbal, N Bogdanovic, B Winblad, R F Cowbur. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain research. vol 797. issue 2. 1998-08-06. PMID:9666145. |
we studied the distribution of cdk5 immunoreactivity in neurons with or without early- and late-stage nfts in hippocampal, entorhinal, transentorhinal, temporal and frontal cortices, and cerebellum of alzheimer's disease (ad) and control brain. |
1998-08-06 |
2023-08-12 |
Not clear |
| C Ceuterick, U Lübke, P Cras, J J Marti. Astroglial tangles in the hippocampus of two patients with Down syndrome and Alzheimer neuropathology. Ultrastructural pathology. vol 22. issue 2. 1998-08-04. PMID:9615386. |
astroglial tangles in the hippocampus of two patients with down syndrome and alzheimer neuropathology. |
1998-08-04 |
2023-08-12 |
Not clear |
| F Kondo, Y Kondo, M Gómez-Vargas, N Ogaw. Indomethacin inhibits delayed DNA fragmentation of hippocampal CA1 pyramidal neurons after transient forebrain ischemia in gerbils. Brain research. vol 791. issue 1-2. 1998-08-03. PMID:9593992. |
we examined the effect of indomethacin on ischemic-induced delayed hippocampal neuronal death in gerbils using the tunel staining method, since indomethacin is neuroprotective in a variety of degenerative processes, such as alzheimer's disease. |
1998-08-03 |
2023-08-12 |
Not clear |
| C Geul. Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology. vol 51. issue 1 Suppl 1. 1998-07-30. PMID:9674759. |
abnormalities of neural circuitry in alzheimer's disease: hippocampus and cortical cholinergic innervation. |
1998-07-30 |
2023-08-12 |
Not clear |
| J Deckert, F Abel, G Künig, J Hartmann, D Senitz, H Maier, G Ransmayr, P Riedere. Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity. Neuroscience letters. vol 244. issue 1. 1998-07-28. PMID:9578130. |
the density of hippocampal adenosine a1 receptors was measured in autopsy samples of six patients with dementia with either alzheimer (three) or sclerosis type pathology (three) in hippocampus and six control patients. |
1998-07-28 |
2023-08-12 |
human |
| J Deckert, F Abel, G Künig, J Hartmann, D Senitz, H Maier, G Ransmayr, P Riedere. Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity. Neuroscience letters. vol 244. issue 1. 1998-07-28. PMID:9578130. |
these results suggest that loss of hippocampal adenosine a1 receptors in dementia is not specific for alzheimer type pathology. |
1998-07-28 |
2023-08-12 |
human |
| L D Morrison, X C Cao, S J Kis. Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. Journal of neurochemistry. vol 71. issue 1. 1998-07-09. PMID:9648877. |
in the alzheimer's disease group, mean ornithine decarboxylase activity was significantly increased in the temporal cortex (+76%), reduced in occipital cortex (-70%), and unchanged in hippocampus and putamen. |
1998-07-09 |
2023-08-12 |
human |
| A D Lawrence, B J Sahakia. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems. Neurochemical research. vol 23. issue 5. 1998-06-19. PMID:9566619. |
the primary pathology in alzheimer's disease (dat) occurs in the basal forebrain cholinergic system (bfcs), which provides the major cholinergic innervation to the neocortex, hippocampus and amygdala. |
1998-06-19 |
2023-08-12 |
Not clear |
| P Giannakopoulos, E Kövari, L E French, I Viard, P R Hof, C Boura. Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta neuropathologica. vol 95. issue 4. 1998-06-12. PMID:9560017. |
recent studies have shown a substantial increase in clusterin mrna in pyramidal neurons of the hippocampus and the entorhinal cortex in alzheimer's disease (ad), with clusterin immunoreactivity occurring in neuropil threads, neurofibrillary tangles (nft), and senile plaques. |
1998-06-12 |
2023-08-12 |
Not clear |
| M P Laakso, H Soininen, K Partanen, M Lehtovirta, M Hallikainen, T Hänninen, E L Helkala, P Vainio, P J Riekkine. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiology of aging. vol 19. issue 1. 1998-06-12. PMID:9562499. |
mri of the hippocampus in alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. |
1998-06-12 |
2023-08-12 |
human |
| M P Laakso, H Soininen, K Partanen, M Lehtovirta, M Hallikainen, T Hänninen, E L Helkala, P Vainio, P J Riekkine. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiology of aging. vol 19. issue 1. 1998-06-12. PMID:9562499. |
in this study, magnetic resonance imaging (mri) of the hippocampus for the diagnosis of early alzheimer's disease (ad) is evaluated. |
1998-06-12 |
2023-08-12 |
human |
| S Kar, A M Issa, D Seto, D S Auld, B Collier, R Quirio. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. Journal of neurochemistry. vol 70. issue 5. 1998-05-18. PMID:9572306. |
the characteristic pathological features of the postmortem brain of alzheimer's disease (ad) patients include, among other features, the presence of neuritic plaques composed of amyloid beta-peptide (a beta) and the loss of basal forebrain cholinergic neurons, which innervate the hippocampus and the cortex. |
1998-05-18 |
2023-08-12 |
rat |
| J N Joyce, A J Myers, E Gurevic. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain research. vol 784. issue 1-2. 1998-04-30. PMID:9518532. |
joyce, c. kaeger, h. ryoo, s. goldsmith, dopamine d2 receptors in the hippocampus and amygdala in alzheimer's disease, neurosci. |
1998-04-30 |
2023-08-12 |
human |